531
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden

, , , , , , & show all
Pages 61-68 | Received 06 Jun 2016, Accepted 18 Aug 2016, Published online: 06 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Martin Kåberg, Simon B. Larsson, Anna Jerkeman, Anders Nystedt, Ann-Sofi Duberg, Jan Kövamees, Magdalena Ydreborg, Soo Aleman, Katharina Büsch, Marianne Alanko Blomé, Ola Weiland & Jonas Söderholm. (2020) High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder. Scandinavian Journal of Gastroenterology 55:5, pages 574-580.
Read now
Midori Kjellin, Hege Kileng, Dario Akaberi, Navaneethan Palanisamy, Ann-Sofi Duberg, Astrid Danielsson, Magnhild Gangsøy Kristiansen, Johan Nöjd, Soo Aleman, Tore Gutteberg, Rasmus Goll, Anders Lannergård & Johan Lennerstrand. (2019) Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway. Scandinavian Journal of Gastroenterology 54:8, pages 1042-1050.
Read now
Hege Kileng, Midori Kjellin, Dario Akaberi, Assar Bergfors, Ann-Sofi Duberg, Lars Wesslén, Astrid Danielsson, Magnhild Gangsøy Kristiansen, Tore Gutteberg, Rasmus Goll, Anders Lannergård & Johan Lennerstrand. (2018) Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014–2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy. Scandinavian Journal of Gastroenterology 53:10-11, pages 1347-1353.
Read now

Articles from other publishers (9)

Michelle Ng, Patrizia Maria Carrieri, Lindila Awendila, Maria Eugenia Socías, Rod Knight & Lianping Ti. (2024) Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review. Canadian Journal of Gastroenterology and Hepatology 2024, pages 1-23.
Crossref
A. Sirinawasatien & T. Techasirioangkun. (2020) The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients. Gastroenterology Research and Practice 2020, pages 1-7.
Crossref
Katharina Büsch, Fredrik Hansson, Michelle Holton, Martin Lagging, Johan Westin, Jan Kövamees, Matti Sällberg & Jonas Söderholm. (2020) Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: a nationwide register study. BMJ Open 10:9, pages e035996.
Crossref
Soo Aleman, Jonas Söderholm, Katharina Büsch, Jan Kövamees & Ann‐Sofi Duberg. (2020) Frequent loss to follow‐up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virus. Liver International 40:8, pages 1832-1840.
Crossref
H. Kileng, T. Gutteberg, R. Goll & E. J. Paulssen. (2019) Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study. BMC Infectious Diseases 19:1.
Crossref
Jonas Söderholm, Aylin Yilmaz, Anders Svenningsson, Katharina Büsch, Rune Wejstål, Alma Brolund, Jan Kövamees, Matti Sällberg, Martin Lagging & Magnus Gisslén. (2019) Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study. Journal of Neurology 266:9, pages 2208-2215.
Crossref
P. Frisk, K. Aggefors, T. Cars, N. Feltelius, S. A. Loov, B. Wettermark & O. Weiland. (2018) Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden. European Journal of Clinical Pharmacology 74:7, pages 971-978.
Crossref
Jonas Söderholm, Charlotta Millbourn, Katharina Büsch, Jan Kövamees, Robert Schvarcz, Karin Lindahl & Annette Bruchfeld. (2018) Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis. Journal of Hepatology 68:5, pages 904-911.
Crossref
Lawrence Serfaty. (2017) Metabolic Manifestations of Hepatitis C Virus. Clinics in Liver Disease 21:3, pages 475-486.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.